Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors
Key Highlights
- ➤Suresh Durgam appointed to Helus Pharma’s Board, pending Cboe Canada approval
- ➤Durgam previously served as Helus Pharma’s Scientific Advisory Board member
- ➤Helus Pharma developing HLP003 in Phase 3 for adjunctive major depressive disorder treatment
- ➤HLP003 has FDA Breakthrough Therapy Designation; HLP004 is in Phase 2 for generalized anxiety disorder
Expert Statements
Michael Halstead, Chief Executive Officer of Helus Pharma
“Suresh’s deep expertise in CNS clinical development, regulatory strategy and scientific leadership has already been valuable to us as a member of our Scientific Advisory Board, and we are delighted to welcome him to our Board”
Michael Halstead, Chief Executive Officer of Helus Pharma
“As we execute against our upcoming clinical, regulatory and commercial milestones, his experience bringing CNS therapies through FDA approval will be invaluable as we advance our pipeline toward potential commercialization.”
Suresh Durgam, Board member of Helus Pharma
“Helus Pharma is advancing a differentiated CNS pipeline with the potential to address significant unmet needs in mental health”
Suresh Durgam, Board member of Helus Pharma
“I look forward to contributing to the Board’s oversight and strategy as Helus Pharma advances its programs through late-stage development.”
This news release constitutes a “designated news release” for the purpose of the Company’s prospectus supplement dated December 30, 2025, to its short form base shelf prospectus dated September 17, 2025, as amended on December 19, 2025.
NEW YORK and TORONTO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Helus Pharma Inc. (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today announced the appointment of Suresh Durgam, M.D., to its Board of Directors. Dr. Durgam previously served on the Company’s Scientific Advisory Board.
Get started
Create a free account to read the full story.